For people with absorption problems, such as pernicious anaemia, injections are medically necessary as oral supplements will not be absorbed effectively
The integration of these therapies into clinical practice should emphasize individualized decision-making, close monitoring, and combination with behavioral and lifestyle interventions
1 The Latest Data To further address gaps in the understanding of mental health and GLP-1 medications, investigators designed a retrospective cohort study using a large epidemiologic database
10.7%) The SURMOUNT-4 trial had 783 obese adults without T2D take tirzepatide for 36 weeks (not blinded), working their way up to their maximum tolerated dose
National Institute of Health (NIH), after analyzing weights and cardiovascular, metabolic risk factors a year after suspending the Wegovy treatment, patients regained two-thirds of the lost weight on average, and their cardiovascular, metabolic risk factors also returned to similar levels to changed weights
Here's the thing nobody tells you about GLP-1 medications: the medication does its job incredibly wellmaybe too well